---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-112977"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T20:20:49.207221+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics receives Nasdaq delisting determination for non-compliance with stockholders' equity requirement

## Summary
- Nasdaq notified Iterum on Oct 1, 2024 that it failed to meet terms of extension to comply with minimum $2.5M stockholders' equity requirement.
- Company intends to request a hearing before Nasdaq Hearings Panel; delisting stayed pending hearing conclusion.
- At hearing, Iterum will present a plan to regain compliance; Panel may grant extension up to March 31, 2025.
- Ordinary shares continue trading on Nasdaq Capital Market under symbol ITRM pending hearing process outcome.
- No assurance that Panel will grant extension or that company will ultimately regain compliance.

## SEC filing metadata
- accession: 0000950170-24-112977
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000095017024112977/0000950170-24-112977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000095017024112977/itrm-20241001.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-112977
- JSON: https://secwatch.observer/filing/0000950170-24-112977.json
- Plain text: https://secwatch.observer/filing/0000950170-24-112977.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.